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Abstract. In recent years, researches have paid much attention to the physical, chemical, biophysical and biochemical 
properties of a cell surface. It is known that most of the cells’ surfaces are charged. This charge depends on the 
biochemical structure of the cell membranes. Therefore, measurement of a cell surface charge is a significant criterion 
that gives information about the cell surface. Evaluation of the cells zeta-potential is important to understand the 
interaction mechanisms of various drugs, antibiotics, as well as the interaction of nanoparticles with the cell surface. In 
this study, we use the dynamic light scattering method to detect the zeta-potential change of Neuro-2a tumor cells. It has 
been observed that zeta-potential shifted to negative values after exposure to metal oxide nanoparticles and inducing 
apoptosis. 
INTRODUCTION 
The onrush of nanotechnologies offers more and more synthesized nanoparticles and materials based on them. 
Many concerns arise as regards to their potential toxicity to mammalian and also human cells. The following 
methods for studying cells characteristics were used: Raman spectroscopy [1], dielectric spectroscopy [2], and NMR 
spectroscopy techniques [3]. But these methods have a range of disadvantages such as relatively expensive reagents, 
heating and labour input. In cell biology zeta potential is one of the key physicochemical parameters of 
nanoparticles exposure on cells (erythrocytes, leukocytes, thrombocytes, etc.) [4], which characterizes the cell 
surface electrical double-layer potential. The cell-surface zeta-potential depends on the composition of the 
cytoplasmic membrane and physiological condition of the cells [5]. Previous studies have shown that cancer 
cells are more electronegative than normal proliferating cells [6].  
 
 
FIGURE 1. Image of Neuro-2a cells 
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FIGURE 2. TEM image of AlN/Al nanoparticles 
Micro-electrophoresis and capillary electrophoresis have been conventionally used for detecting zeta potential of 
the cells. The electrophoretic light scattering technique based on dynamic light scattering (DLS), in which the 
frequency shift or phase shift of the laser beam depends on the mobility of particles or cells in an alternating electric 
field, is a promising alternative to these methods [5]. 
Alumina is widely used in various medical applications such as regenerative medicine [7, 8], cancer treatment 
[9], drug delivery [10, 11] and biosensing methods [12] for its unique physical and chemical properties and low 
toxicity. Earlier we produced low-dimensional alumina nanostructures by AlN/Al nanoparticles oxidation with water 
[13–16]. The low-dimensional alumina-based materials have been successfully used as a wound dressing [17]. In 
vitro studies have shown that low-dimensional alumina structures display different toxic effect on L929 and Neuro-
2a cell lines. Alumina nanosheets exhibited a more pronounced adverse effect on cells as compared to alumina 
nanoplates and agglomerates of alumina nanosheets. 
In this study, low-dimensional alumina nanostructures were prepared via reaction of the AlN/Al nanopowders 
with water under different conditions. A Neuro-2A (N2A) mouse neuroblastoma cell line was used to determine the 
potential toxic effect of the structures. Zeta-potential measurements were used to detect changes in cancer cells 
(Neuro-2a) surface charge after the exposure to alumina nanoparticles. 
MATERIAL AND METHODS 
AlN/Al nanoparticles were produced by the electrical explosion of aluminum wire in a nitrogen atmosphere [18–
20]. The mass ratio of aluminum and aluminum nitride in the nanopowder was 30 : 70 wt. %. There were three 
methods to obtain low-dimensional alumina nanostructures—the reaction of AlN/Al with water, the hydrothermal 
synthesis, and the oxidation of AlN/Al in wet air. The reaction of AlN/Al nanopowder with water was carried out 
according to the method in [13]. For this 1 g of precursor was added to 100 ml of deionized water. Then, the 
suspension was incubated on a water bath with stirring at 60°C for 1 h. The reaction products were separated by 
centrifugation, washed several times with deionized water, and finally dried at 120°C for 2 h. In the hydrothermal 
process, 1 g of AlN/Al nanopowder is treated with 100 ml of deionized water in a stainless steel autoclave with a 
Teflon insert at room temperature. The hydrothermal treatment was performed at 200°C for 6 h. The oxidation of 
AlN/Al nanopowder in wet air [21] was performed in the climatic chamber TXW-60 at 60°C and 80% relative 
humidity for 24 h. The reaction products were dried at 100°C for 2 h. 
The morphology of the low-dimensional alumina structures was examined by scanning electron microscopy 
(LEO EVO 50, operated at 30 kV), transmission electron microscopy (JEOL JEM-2100, Japan, operated at 200 kV), 
and X-ray diffraction (XRD-6000, Cu-K? radiation, wavelength 1.54056 Å). A specific surface area was estimated  
by nitrogen adsorption on a Sorbtometer M device (Katakon, Russia) and was calculated by the BET method at a 
relative pressure of 0.05?0.35. 
TABLE 1. Sample characteristics 
Sample Shape 
Synthesis method Specific surface 
area, m2/g
Zeta potential, 
mV 
Phase composition 
(Fig. 3) 
Sample 1 Nanopetals Water oxidation 280 30 Pseudoboehmite 
Sample 2 Nanoplates Hydrothermal synthesis 71 31 Boehmite 
Sample 3 Wedge-like Wet air oxidation 22 33 Bayerit 
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FIGURE 3. TEM image of alumina nanostructures: (a) alumina nanopetals; (b) alumina nanoplates; (c) wedge-like alumina 
 
The mouse neuroblastoma Neuro-2a cell line (Fig. 1) was purchased from Vector, Koltsovo (Russian Federation). 
Cells were cultured as monolayer in Eagle’s minimum essential medium (MEM) supplemented with 10% of fetal 
bovine serum (FBS), 2 mM L-glutamine and 1% penicillin-streptomycin in 75 cm2 flasks at 37°? in a humidified 
atmosphere containing 5% CO2. Before treating, samples of alumina nanostructures (0.08 g) were suspended in 
20 ml of culture medium. Cells were seeded on 24-well plates (total volume of 2 ml) at 160 000 cells per well. The 
suspension of low-dimensional structures (1 ml) was added in each well except for the control one. Cells were 
incubated for 12, 24, and 48 h.  
The number of cells was counted using a hemocytometer with trypan blue staining. The control group was the 
initial culture with no contact with low-dimensional structures. For statistical data processing, parametric methods 
with a significance level of ? ? 0.05 were used. After incubation, cells were washed three times with Phosphate 
Buffered Saline (PBS), and then detached using a Trypsin-Versene solution (Invitrogen). After that, cells were 
centrifuged down and resuspended in PBS (pH 7.2) for Zeta-potential measurements. The zeta-potential of the cells 
was determined using a DLS (dynamic light scattering detector) (Zetasizer Nano ZSP, Malvern Instruments Ltd, 
UK) at 25°C. Usually, AlN/Al nanoparticles have a faceted form (Fig. 2). According to EDAX-TEM analysis data, 
aluminum and nitrogen are uniformly distributed throughout all the particles [13]. These particles constitute a 
composite with a core-shell structure, where the core is the metallic aluminum and the shell is the aluminum nitride. 
RESULT AND DISCUSSION 
AlN/Al nanoparticles are chemically active and interact with water at 60°C. The reaction is exothermic and 
accompanied by the release of hydrogen and a change in the pH of the reaction medium. The reaction products have 
a nanopetal form with the thickness of 5–10 nm and the planar dimension of approximately 150–300 nm (Fig. 3a). 
According to the X-ray phase analysis, the main component of these products is a poorly crystallized 
pseudoboehmite AlOOH (Fig. 4a) [16].  
 
 
(a) (b) (c) 
FIGURE 4. XRD spectra of alumina nanostructures: (a) alumina nanopetals; (b) alumina nanoplates; (c) wedge-like alumina 
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TABLE 2. Zeta potential (?) and cell viability (CV) of Neuro-2a cells after the exposure to alumina nanostructures 
Exposure time 
12 h 24 h 48 h Sample 
?, mV CV, % ?, mV CV, % ?, mV CV, % 
Nanopetals –25.3 ± 0.2 100.5 ± 3.2 –26.3 ± 0.2 78.4 ± 2.0 –29.4 ± 0.3 64.4 ± 3.3 
Nanoplates –22.8 ± 0.1 106.0 ± 1.2 –22.9 ± 0.2 89.2 ± 1.1 –26.3 ± 0.1 82.8 ± 1.0 
Wedge-like  –22.5 ± 0.3 107.5 ± 1.3 –22.2 ± 0.3 107.4 ± 3.0 –22.7 ± 0.2 108.0 ± 2.3 
Control –21.9 ± 0.3 102.3 ± 1.4 –22.3 ± 0.1 99.5 ± 1.2 –22.0 ± 0.2 99.2 ± 1.5 
 
The specific surface area of the alumina nanopetals is approximately 280 m2·g–1, and the zeta potential is 30 ± 
3 mV (sample 1). The alumina plates (sample 2), which have an irregular shape with a size of 40–100 nm and a 
thickness of 4–15 nm, are formed after hydrothermal treatment with AlN/Al nanopowders (Fig. 3b). According to 
TEM, the products of AlN/Al oxidation in wet air are nonporous wedge-like structures (sample 3) with planar 
dimensions approximately 150–300 nm (Fig. 3c). The characteristics of the low-dimensional nanostructures are 
summarized in Table 1. 
Experimental results revealed that alumina nanostructures have effect on viability and zeta-potential of tumor 
cells (Table 2). After 12, 24 and 48 hours of nanopetals exposure on Neuro-2a cells the viability decreased from 
100.5 ± 3.2 to 64.4 ± 3.3%. At the same time, zeta-potential of the cells slightly changed to more negative values  
(–25.3 ± 0.2) than that of the control ones (–21.9 ± 0.3) even after 12 hours of contact with nanopetals. This 
tendency continued after 24 and 48 hours of exposure, with zeta-potential being –26.3 ± 0.2 and –29.4 ± 0.3, 
respectively. No change in zeta potential was detected after 12 and 24 hours of incubation with nanoplates. There 
was also some effect on viability of the cells. The maximum decrease in zeta-potential was observed after 48 hours 
of exposure, and viability of the cells also reduced. Table 2 shows that wedge-like alumina structures did not affect 
Neuro-2a tumor cells at all the time points. 
According to the results obtained using the DLS technique, the average zeta potential of cells after the contact 
with nanostructures shifted towards negative values, as compared to the control ones. It is presumably a result of 
redistribution of phosphatidylserine bearing a negatively charged carboxyl group from the inner to the outer lipid 
layer. The emergence of phosphatidylserine in the outer lipid monolayer of the cell membrane is one of the earliest 
markers of apoptosis and reduction in cell viability [22]. 
CONCLUSION 
Aluminum oxide nanostructures were obtained under laboratory conditions with various morphologies and 
specific surface areas, but having the same zeta-potential (30 mV). The study of zeta-potential change of tumor cells 
after exposure to nanostructures was performed. It revealed that the biggest change of zeta-potential and viability of 
the cells was observed with nanopetals. Nanoplates had less effect on zeta-potential and cell proliferation change. 
Wedge-like alumina did not exhibit any effect on zeta-potential and viability of the cells. Thus, measurement of 
zeta-potential of the cells or cell surface charge with the DLS technique is a significant criterion that gives 
information about cell proliferation. It was proved that zeta-potential is an early marker of the altered cell viability. 
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